SCHEMBL21048971

SCHEMBL21048971

COc1ccc(COC2(c3ccc(Cl)cc3F)CC[C](O)CC2)cc1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.37
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CNR1 P21554 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
ADRB3 P13945 1/20 0.35
MAPT P10636 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17542690 0.89 KCNA5 (0.41) KCNA5ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL17542840 0.89 KCNA5 (0.37) KCNA5ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL17543517 0.85 MEN1 (0.37) KCNA5ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL21048952 0.83 BACE1 (0.36) KCNA5ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL17543027 0.83 BACE1 (0.36) KCNA5ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL17543058 0.83 BACE1 (0.36) KCNA5ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL17543986 0.83 ALDH1A1 (0.38) KCNA5ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL17542730 0.76 KEAP1 (0.36) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL17542731 0.76 KEAP1 (0.36) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL17542733 0.76 KEAP1 (0.36) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3186240-B1 HETEROBICYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2019-06-12 EP disclosed